Not Yet Recruiting
Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study
NCT07264010
- Conditions
- Acute Myeloid Leukaemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
Not specified